Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02386540 · ClinicalTrials.gov registry record · NA

Health Coach Program to Improve Chronic Disease Outcomes Following an Emergency Department Visit

A NA study of Hypertension and Diabetes Mellitus, sponsored by Alameda County Medical Center.

Completed
Registry status
NA
Development phase
295
Enrollment target
1
Study location

NCT02386540: Completed NA study of Hypertension and Diabetes Mellitus, sponsored by Alameda County Medical Center.

NCT02386540 is a NA study of Hypertension and Diabetes Mellitus that has completed, run by Alameda County Medical Center. The registered enrollment target is 295 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02386540, a NA study of Hypertension and Diabetes Mellitus, has completed, sponsored by Alameda County Medical Center.

COMPLETED
Registry status
NA
Development phase
295 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether health coaching initiated in the emergency department (ED) reduces subsequent ED visits, increases primary care visits, and positively impacts health outcomes in patients with diabetes and/or hypertension.

Primary Outcome

Self-reported measure collected via follow-up phone surveys at 1, 3, and 6 months.

Interventions

  • BEHAVIORAL Health Coaching

Study Locations (1)

California

  • Highland Hospital - Alameda Health System - Oakland

Trial Details

FieldValue
Enrollment Target 295 participants
Start Date 2015-02-06
Est. Completion 2018-12-10
Phase NA
Alameda County Medical Center

2 total trials

What the finished NCT02386540 record still lists

NCT02386540 is an interventional study that assigns participants to a tested intervention. The registered 295 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (92% lower).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Health Coaching is the first listed.

NCT02386540 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02386540 about?

NCT02386540 is a clinical study titled "Health Coach Program to Improve Chronic Disease Outcomes Following an Emergency Department Visit". The purpose of this study is to determine whether health coaching initiated in the emergency department (ED) reduces subsequent ED visits, increases primary care visits, and positively impacts health outcomes in patients with diabetes and/or hypertension.

What is the current status of trial NCT02386540?

This trial is currently completed. It is a NA study. The enrollment target is 295 participants. The study started on 2015-02-06. Estimated completion is 2018-12-10.

What conditions does trial NCT02386540 study?

This clinical trial studies the following conditions: Hypertension, Diabetes Mellitus.

What interventions are being tested in trial NCT02386540?

The interventions under investigation include: Health Coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT02386540?

This trial is sponsored by Alameda County Medical Center, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02386540 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02386540's enrollment target sits among peer trials

295 182nd of 470 higher than 289 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05201781 · 295 participants · Phase 4

    A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

  • NCT06004245 · 295 participants · Phase 1

    A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

  • NCT06494111 · 295 participants · Phase 2

    Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)

  • NCT07020221 · 295 participants · Phase 1

    A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02386540, the US trial registry maintained by the National Library of Medicine. NCT02386540 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.